NPI: 1073963138 · PAHRUMP, NV 89048 · General Acute Care Hospital · NPI assigned 06/20/2016
Authorized official FILTON, STEVE controls 20+ related entities in our dataset. Read more
| Authorized Official | FILTON, STEVE (VICE PRESIDENT) |
| NPI Enumeration Date | 06/20/2016 |
Other providers sharing the same authorized official: FILTON, STEVE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 59,731 | $1.70M |
| 2019 | 77,006 | $1.81M |
| 2020 | 64,448 | $1.59M |
| 2021 | 69,915 | $1.91M |
| 2022 | 81,460 | $2.00M |
| 2023 | 83,894 | $2.13M |
| 2024 | 75,547 | $1.65M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 21,285 | 16,752 | $2.70M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 16,013 | 13,800 | $2.12M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4,284 | 3,477 | $1.85M |
| G0378 | Hospital observation service, per hour | 5,013 | 1,895 | $1.78M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3,220 | 2,757 | $1.07M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 15,831 | 14,147 | $1.06M |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1,260 | 1,039 | $486K |
| 72125 | Computed tomography, cervical spine; without contrast material | 1,770 | 1,527 | $471K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 1,527 | 1,284 | $300K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2,608 | 2,277 | $226K |
| 70450 | Computed tomography, head or brain; without contrast material | 5,491 | 4,547 | $165K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 3,318 | 2,984 | $60K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 6,363 | 4,265 | $54K |
| 96375 | Therapeutic injection; each additional sequential IV push | 15,445 | 10,908 | $54K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 844 | 805 | $40K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 986 | 209 | $32K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 16,273 | 12,464 | $22K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 20,278 | 15,231 | $20K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1,365 | 269 | $18K |
| 96361 | Intravenous infusion, hydration; each additional hour | 11,096 | 8,722 | $18K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 798 | 604 | $12K |
| 77066 | Tomosynthesis, mammo | 80 | 68 | $12K |
| 93971 | 162 | 146 | $11K | |
| J3490 | Unclassified drugs | 8,295 | 3,787 | $10K |
| 80053 | Comprehensive metabolic panel | 30,617 | 21,150 | $9K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4,600 | 3,835 | $8K |
| 96376 | 5,593 | 3,267 | $8K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 5,156 | 4,487 | $7K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 33,266 | 23,033 | $7K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 8,017 | 6,017 | $7K |
| 71045 | Radiologic examination, chest; single view | 18,255 | 14,369 | $7K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 458 | 377 | $7K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 36 | 36 | $7K |
| 76642 | 536 | 471 | $7K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 876 | 744 | $7K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 644 | 494 | $6K |
| 71046 | Radiologic examination, chest; 2 views | 1,984 | 1,733 | $6K |
| 76830 | Ultrasound, transvaginal | 64 | 58 | $5K |
| 84484 | 22,524 | 11,726 | $5K | |
| 83880 | 7,483 | 5,855 | $5K | |
| 94060 | 37 | 37 | $4K | |
| 71250 | 103 | 77 | $4K | |
| 72100 | 271 | 247 | $4K | |
| 84443 | Thyroid stimulating hormone (TSH) | 2,663 | 1,951 | $3K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 70 | 69 | $3K |
| 97162 | 44 | 37 | $3K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 2,112 | 1,882 | $3K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4,263 | 3,773 | $3K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 3,450 | 2,491 | $3K |
| 73562 | 653 | 555 | $2K | |
| 99070 | 17 | 12 | $2K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 18 | 12 | $2K |
| 36415 | Collection of venous blood by venipuncture | 34,639 | 23,917 | $2K |
| 73630 | 597 | 506 | $2K | |
| 78454 | 34 | 26 | $2K | |
| 85730 | 13,820 | 10,793 | $2K | |
| 83735 | 12,427 | 8,205 | $2K | |
| 83690 | 9,610 | 7,618 | $2K | |
| 73130 | 680 | 568 | $2K | |
| 84703 | 7,673 | 6,434 | $2K | |
| 83605 | 7,432 | 5,726 | $2K | |
| 82553 | 7,022 | 5,469 | $2K | |
| 72131 | 27 | 24 | $2K | |
| 94664 | 3,339 | 2,648 | $2K | |
| 73610 | 688 | 602 | $2K | |
| 73030 | 656 | 557 | $2K | |
| 80050 | General health panel | 121 | 118 | $1K |
| 81000 | 16,732 | 13,621 | $1K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 43 | 37 | $1K |
| 85610 | 14,464 | 11,128 | $1K | |
| 77065 | Tomosynthesis, mammo | 12 | 12 | $1K |
| 82550 | 9,509 | 7,367 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1,272 | 1,040 | $1K |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 572 | 496 | $1K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 4,935 | 4,163 | $1K |
| 90715 | 702 | 615 | $1K | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | 3,269 | 2,485 | $976.41 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 6,321 | 5,234 | $964.42 |
| 87040 | 2,027 | 1,397 | $700.65 | |
| 73110 | 170 | 149 | $683.81 | |
| 80061 | Lipid panel | 1,524 | 1,123 | $634.94 |
| 80048 | Basic metabolic panel (calcium, ionized) | 2,412 | 2,075 | $594.55 |
| J7030 | Infusion, normal saline solution , 1000 cc | 3,238 | 2,345 | $463.22 |
| 0450 | Emergency room services | 13 | 12 | $457.23 |
| 84702 | 781 | 658 | $456.39 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 117 | 102 | $455.64 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 1,757 | 1,611 | $450.40 |
| 70486 | 15 | 12 | $448.88 | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 33 | 26 | $435.95 |
| 82803 | 600 | 433 | $423.63 | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 101 | 89 | $372.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,374 | 1,019 | $360.18 |
| 85378 | 1,586 | 1,368 | $355.61 | |
| 87070 | 1,505 | 1,125 | $342.82 | |
| 87430 | 1,200 | 1,102 | $263.01 | |
| 86756 | 575 | 540 | $246.64 | |
| 87088 | 958 | 858 | $221.15 | |
| 36600 | 523 | 374 | $170.65 | |
| 94727 | 36 | 36 | $155.70 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 997 | 791 | $147.51 |
| 94762 | 544 | 464 | $143.36 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 65 | 56 | $140.66 |
| 93015 | 35 | 27 | $133.84 | |
| 94761 | 1,888 | 671 | $109.81 | |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 83 | 77 | $96.07 |
| 94644 | 90 | 84 | $96.06 | |
| 51702 | 41 | 27 | $83.71 | |
| 77080 | 12 | 12 | $82.42 | |
| 96368 | 191 | 159 | $72.20 | |
| 80329 | 1,848 | 1,270 | $60.17 | |
| J2060 | Injection, lorazepam, 2 mg | 257 | 223 | $55.30 |
| 87186 | 191 | 161 | $54.02 | |
| J1790 | Injection, droperidol, up to 5 mg | 157 | 146 | $52.63 |
| 73590 | 44 | 39 | $49.18 | |
| 73080 | 20 | 15 | $48.79 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 560 | 513 | $47.46 |
| J1094 | Injection, dexamethasone acetate, 1 mg | 67 | 63 | $29.11 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 1,252 | 1,096 | $27.88 |
| 96367 | 192 | 157 | $26.69 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1,529 | 1,280 | $26.32 |
| 51701 | 29 | 25 | $26.08 | |
| J7050 | Infusion, normal saline solution, 250 cc | 249 | 208 | $25.13 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 94 | 86 | $22.81 |
| 87077 | 213 | 183 | $22.08 | |
| 74018 | 29 | 28 | $18.54 | |
| 82150 | 166 | 139 | $17.81 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 259 | 211 | $17.43 |
| 86901 | 159 | 139 | $16.47 | |
| 82272 | 75 | 67 | $11.17 | |
| 86140 | 120 | 101 | $10.86 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 83 | 77 | $8.71 |
| J3370 | Injection, vancomycin hcl, 500 mg | 90 | 79 | $6.08 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 227 | 207 | $5.85 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 20 | 12 | $4.80 |
| 85652 | 41 | 39 | $3.83 | |
| J3480 | Injection, potassium chloride, per 2 meq | 98 | 76 | $3.50 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 201 | 182 | $2.44 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 114 | 100 | $2.40 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 89 | 83 | $1.81 |
| 82962 | 141 | 118 | $1.23 | |
| J1815 | Injection, insulin, per 5 units | 20 | 13 | $1.15 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 214 | 202 | $1.08 |
| J1171 | Injection, hydromorphone, 0.1 mg | 30 | 26 | $0.27 |
| 82565 | 67 | 65 | $0.00 | |
| J7510 | Prednisolone oral, per 5 mg | 140 | 134 | $0.00 |
| 01999 | 30 | 26 | $0.00 | |
| S0028 | Injection, famotidine, 20 mg | 111 | 95 | $0.00 |
| 84439 | 29 | 24 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 53 | 52 | $0.00 |
| S0164 | Injection, pantoprazole sodium, 40 mg | 29 | 25 | $0.00 |
| 84520 | 67 | 65 | $0.00 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 197 | 162 | $0.00 |
| 94729 | 37 | 37 | $0.00 | |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 19 | 15 | $0.00 |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 18 | 18 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 71 | 63 | $0.00 |
| 80320 | 3,503 | 2,885 | $0.00 | |
| 86850 | 34 | 27 | $0.00 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 52 | 50 | $0.00 |
| J3360 | Injection, diazepam, up to 5 mg | 26 | 24 | $0.00 |
| G0202 | Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed | 71 | 36 | $0.00 |
| 84132 | 40 | 25 | $0.00 | |
| 12001 | 27 | 24 | $0.00 |